C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo

Abstract The C957T (rs6277) single nucleotide polymorphism (SNP) of the human dopamine D2 receptor (DRD2) gene ( DRD2 ) affects DRD2 mRNA stability and has been shown to predict striatal DRD2 availability ( B max / K D ) in vivo in man. Specifically, the C/C genotype is associated with low striatal DRD2 availability (C/C BP ND ) measured in 38 healthy male volunteers with 3D-PET and the high-affinity DRD2 radioligand [ 11 C]FLB457. The subjects were genotyped for the C957T as well as for two other widely studied DRD2 SNPs, the TaqIA (rs1800497) and the −141C Ins/Del (rs1799732). Statistical analyses showed that the C957T C/C genotype was associated with high extrastriatal DRD2 BP ND throughout the cortex and the thalamus (C/C>C/T>T/T). Also the TaqIA A1 allele carriers ( p  = 0.101) tended to have higher extrastriatal DRD2 BP ND compared to non-carriers whereas the −141C Ins/Del genotype did not influence extrastriatal DRD2 BP ND . Our findings indicate that the DRD2 SNPs regulate DRD2 availability in the human cortex and in the thalamus in vivo . However, the regulation pattern is different from that observed previously for striatal DRD2 availability in vivo , which may reflect distinct functional roles of dopamine and DRD2 in the cortex versus the striatum. The results provide useful information for the interpretation of genetic studies exploring the role of the DRD2 in normal physiology as well as in psychiatric and neurological diseases.